山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (1): 67-72.doi: 10.6040/j.issn.1671-7554.0.2019.1307
• • 上一篇
张照鹏,邢乃栋,张翔,阎磊,徐忠华
ZHANG Zhaopeng, XING Naidong, ZHANG Xiang, YAN Lei, XU Zhonghua
摘要: 目的 探讨导致腹腔镜根治性膀胱切除术后淋巴漏出现的相关因素,并研究各因素在术后淋巴漏的预防及治疗中的作用。 方法 回顾2015年1月至2019年1月在山东大学齐鲁医院泌尿外科行腹腔镜根治性膀胱切除术患者共计160例,查阅文献并制定标准后将患者分为淋巴漏及非淋巴漏组,收集其年龄、淋巴结清扫范围、淋巴结数量、阳性淋巴结数量、是否存在阳性淋巴结、清扫后是否Hemolock夹闭淋巴组织、术前及术后血红蛋白(HGB)、术后白蛋白(ALB)等临床资料,采用单因素及多因素分析患者术后发生淋巴漏的有关因素。 结果 研究共纳入的160例患者中,其中有44例(27.5%)诊为淋巴漏,单因素t检验及χ2检验显示阳性淋巴结数量、清扫后是否Hemolock夹闭淋巴组织与淋巴漏发生有关联,清扫后Hemolock夹闭淋巴组织可明显降低术后淋巴漏的发生(t=2.477, χ2=41.215, P<0.05),二元Logistic回归分析显示清扫后是否Hemolock夹闭淋巴组织与淋巴漏发生有关联(OR=18.482, 95%CI:6.872~49.709,P<0.001)。患者经禁饮食、通畅引流等保守治疗均治愈。 结论 阳性淋巴结数量及清扫后是否Hemolock夹闭淋巴组织是术后淋巴漏发生的高危因素。通过饮食、引流及其他治疗措施均可治愈,术中熟练地掌握操作技巧、淋巴结清扫后Hemolock夹闭淋巴组织、熟悉解剖和仔细操作可预防淋巴漏发生。
中图分类号:
[1] Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends[J]. Eur Urol, 2017, 71(1): 96-108. [2] Hautmann RE, Abol-Enein H, Hafez K, et al. Urinary diversion[J]. Urology, 2007, 69(Suppl 1): 17-49. [3] 刘杰, 崔伟, 车梓, 等. 经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J]. 山东大学学报(医学版), 2018, 56(7): 81-85. LIU Jie, CUI Wei, CHE Zi, et al. Efficacy of transurethral resection of bladder tumor in the treatment of muscle-invasive bladder cancer[J]. Journal of Shandong University(Health Sciences), 2018, 56(7): 81-85. [4] Tan S, Kang Y, Li H, et al. Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2019, 44(9): 1003-1008. [5] Tang K, Li H, Xia D, et al. Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies[J]. PLoS One, 2014, 9(5): e95667.doi: 10.1371/journal.pone.0095667. [6] Simone G, Papalia R, Ferriero M, et al. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy[J]. Int J Urol, 2013, 20(4): 390-397. [7] Kim EA, Park H, Jeong SG, et al. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma[J]. J Obstet Gynaecol Res, 2014, 40(2): 622-626. [8] Shao P, Meng X, Li J, et al. Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes[J]. BJU Int, 2011, 108(1): 124-128. [9] 赵宇清, 谭鑫, 胡卫国. 腹腔镜下淋巴结清扫术后并发淋巴漏的临床分析[J]. 现代妇产科进展, 2013, 22(6): 449-452. ZHAO Yuqing, TAN Xin, HU Weiguo. Clinical analysis of the lymphorrhagia after laparoscopic lymphadenectomy in gynecologic malignancies[J]. Progress in Obstetrics and Gynecology, 2013, 22(6): 449-452. [10] 李培全, 刘青, 刘开江, 等. 妇科恶性肿瘤腹腔镜淋巴结清扫术后淋巴漏的影响因素及治疗方法[J] 中国内镜杂志, 2018, 24(12): 43-49. LI Peiquan, LIU Qing, LIU Kaijiang, et al. Risk factors and treatment of lymph leakage after laparoscopic gynecological malignant tumor lymph node dissection[J] China Journal of Endoscopy, 2018, 24(12): 43-49. [11] Nishigori H, Ito M, Nishizawa Y, et al. Postoperative chylous ascites after colorectal cancer surgery[J]. Surg Today, 2012, 42(8): 724-728. [12] Hulusi M, Ozbek C, Basaran M, et al. Is saphenofemoral junction reconstruction necessary during stripping of the saphenous vein?[J]. Surgery, 2006, 139(5): 640-645. [13] Sansalone CV, Aseni P, Minetti E, et al. Is lymphocele in renal transplantation an avoidable complication?[J]. Am J Surg, 2000, 179(3): 182-185. [14] Evans JG, Spiess PE, Kamat AM, et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience[J]. J Urol, 2006, 176(4 Pt 1): 1463-1467. [15] 周家权, 朱耀, 叶定伟. 腹股沟淋巴结清扫术后淋巴漏的危险因素和治疗策略分析[J].现代泌尿生殖肿瘤杂志, 2012, 4(5): 278-281. ZHOU Jiaquan, ZHU Yao, YE Dingwei. An analysis of risk factors and treatment strategies of lymphorrhea following the inguinal lymph node dissection[J]. Journal of Contemporary Urologic and Reproductive Oncology, 2012, 4(5): 278-281. [16] Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection(ILND)in melanoma patients[J]. Ann Surg Oncol, 2010, 17(10): 2764-2772. [17] Bruins HM, Huang GJ, Cai J, et al. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy[J]. J Urol, 2009, 182(5): 2182-2187. [18] 曹晖, 赵恩昊. 胃手术后淋巴漏和乳糜漏原因及防治[J]. 中国实用外科杂志, 2017, 37(4): 355-358. CAO Hui, ZHAO Enhao. Prevention and management of lymphorrhea or chylorrhea after gastric surgeries[J]. Chinese Journal of Practical Surgery, 2017, 37(4): 355-358. [19] 谢礼波, 符磊, 何绍锋, 等. 生长抑素在肾移植后淋巴漏治疗中的应用17例[J]. 中华器官移植杂志, 2013, 34(2): 123-124. XIE Libo, FU Lei, HE Shaofeng, et al. Application of somatostatin in the treatment of lymphatic leakage after renal transplantation in 17 cases[J]. Chinese Journal of Organ Transplantation, 2013, 34(2): 123-124. [20] Karaca S, Gemayel G, Kalangos A. Somatostatin treatment of a persistent chyloperitoneum following abdominal aortic surgery[J]. J Vasc Surg, 2012, 56(5): 1409-1412. [21] Berzigotti A, Magalotti D, Cocci C, et al. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report[J]. Dig Liver Dis, 2006, 38(2): 138-142. [22] Inoue M, Nakatsuka S, Yashiro H, et al. Lymphatic intervention for various types of lymphorrhea: access and treatment[J]. Radiographics, 2016, 36(7): 2199-2211. [23] Solmaz U, Turan V, Mat E, et al. Chylous ascites following retroperitoneal lymphadenectomy in gynecologic malignancies: incidence, risk factors and management[J]. Int J Surg, 2015, 16(Pt A): 88-93. [24] Liu Y, Pan C, Tang JY, et al. What is the result: chylous leakage following extensive radical surgery of neuroblastoma[J]. World J Pediatr, 2012, 8(2): 151-155. [25] Leibovitch I, Mor Y, Golomb J, et al. The diagnosis and management of postoperative chylous ascites[J]. J Urol, 2002, 167(2 Pt 1): 449-457. [26] Kayama E, Nishimoto K, Kaneko G, et al. Embolization Using N-butyl Cyanoacrylate for Postoperative Lymphatic Leakage: A Case Report[J]. Clin Genitourin Cancer, 2018, 16(2): e355-e371. [27] 姜帅, 项卓仪, 郭剑明. 机器人辅助腹腔镜腹膜外入路前列腺癌根治术后淋巴液渗漏防治策略探讨[J]. 上海医学, 2019, 42(3): 174-177. JIANG Shuai, XIANG Zhuoyi, GUO Jianming. Prevention and treatment of lymphatic leakage post robot-assisted laparoscopic radical prostatectomy[J]. Shanghai Medical Journal, 2019, 42(3): 174-177. [28] Lv S, Wang Q, Zhao W, et al. A review of the postoperative lymphatic leakage[J]. Oncotarget, 2017, 8(40): 69062-69075. [29] Valenzuela-Rendon J, Manning R D, Jr. Chronic transvascular fluid flux and lymph flow during volume-loading hypertension[J]. Am J Physiol, 1990, 258(5 Pt 2): H1524-1533. |
[1] | 米琦,史爽,李娟,李培龙,杜鲁涛,王传新. 膀胱癌circRNAs介导的ceRNA网络及预后评估模型的构建[J]. 山东大学学报 (医学版), 2021, 59(6): 94-102. |
[2] | 王健,李健,王勇,朱耀丰. 黄芩素通过抑制PI3K/AKT/mTOR通路诱导膀胱癌细胞凋亡[J]. 山东大学学报 (医学版), 2019, 57(9): 74-82. |
[3] | 刘杰, 崔伟,车梓,崔志强,王策正,王彤,李明,刘玲,杨全成,孙彬,高佃军,聂清生. 经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J]. 山东大学学报 (医学版), 2018, 56(7): 81-85. |
[4] | 蒿魁元,赵圣,张宇,崔迪,荆翌峰,夏术阶,韩邦旻. 雄激素阻断对膀胱癌UM-UC-3细胞自噬与凋亡的影响[J]. 山东大学学报 (医学版), 2018, 56(3): 41-47. |
[5] | 刘益民,杜鲁涛,王丽丽,蒋秀梅,李娟,曲爱林,王海燕,郑桂喜,张欣,杨咏梅,王传新. 膀胱癌患者血清microRNA检测中内参基因的筛选及验证[J]. 山东大学学报(医学版), 2014, 52(5): 86-91. |
[6] | 武广平,厉波,曹勇 . 钬激光联合吡柔比星膀胱灌注治疗非肌层浸润性膀胱癌的临床分析[J]. 山东大学学报(医学版), 2010, 48(12): 97-99. |
|